Latest DEF 14A proxy statements

Arteris, Inc. announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 2, 2026, focusing on director elections and auditor ratification.

Trevi Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 3, 2026, and is seeking shareholder approval to increase its authorized common stock and amend its stock incentive plan.

Heritage Global Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for June 3, 2026, detailing proposals for director elections and auditor ratification.

Standard Motor Products, Inc. has announced its 2026 Annual Meeting of Shareholders, scheduled for May 21, 2026, to vote on director elections, auditor ratification, and executive compensation.

USCB Financial Holdings, Inc. announces its virtual Annual Meeting of Shareholders scheduled for May 26, 2026, to elect directors and ratify auditor appointment.

Mannatech, Incorporated announces its 2026 Annual Shareholders Meeting, scheduled for June 2, 2026, to elect directors, ratify auditors, and vote on executive compensation.

BAB, Inc. has issued a proxy statement announcing its Annual Meeting of Shareholders on June 3, 2026, to elect directors and ratify auditor appointments.

FirstSun Capital Bancorp announces its 2026 Annual Meeting of Stockholders to be held virtually on June 5, 2026, with key proposals including director elections and auditor ratification.

Tecogen Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 5, 2026, to elect directors, ratify auditors, and vote on executive compensation.

EMCOR Group, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, and auditor ratification.

Omega Healthcare Investors announces its 2026 Annual Meeting of Stockholders, scheduled for June 5, 2026, to elect directors, ratify auditor selection, and vote on executive compensation.

Duluth Holdings Inc. has announced its 2026 Annual Meeting of Shareholders, set for June 3, 2026, to elect directors, vote on executive compensation, and ratify auditor appointments.

Blackbaud, Inc. has announced its 2026 Annual Meeting of Stockholders, detailing proposals including advisory vote on executive compensation, an amendment to its equity incentive plan, and ratification of its independent auditor.

CRISPR Therapeutics AG has announced its 2026 Annual General Meeting of Shareholders, scheduled for June 4, 2026, to vote on key corporate matters including financial statements, director elections, and compensation.

FTI Consulting has announced its 2026 Annual Meeting of Shareholders will be held on June 3, 2026, to vote on director elections, auditor ratification, and executive compensation.

Upbound Group, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 2, 2026, to address key corporate matters including director elections and executive compensation.

AIRO Group Holdings, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, detailing proposals for director elections and auditor ratification.

AppLovin Corporation's 2026 Proxy Statement details the upcoming Annual Meeting, focusing on director elections, auditor ratification, executive compensation, and proposed amendments to corporate governance.

Energy Recovery, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 4, 2026, with a record date of April 6, 2026.

OUTFRONT Media Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 3, 2026, with proxy materials available online.

Landmark Bancorp, Inc. announces its 2026 annual meeting, proposing a share authorization increase and auditor change.

RadNet, Inc. has filed its 2026 Proxy Statement, seeking stockholder approval for director elections, auditor ratification, executive compensation, and an amendment to its Equity Incentive Plan.

Open Lending Corporation announces its 2026 Annual Meeting, seeking shareholder approval for a reverse stock split and board declassification.

Shuttle Pharmaceuticals Holdings, Inc. seeks shareholder approval for a reverse stock split of up to 1-for-150 to maintain Nasdaq listing compliance.

Entravision Communications Corporation has issued its 2026 proxy statement, seeking shareholder approval for director elections, auditor ratification, executive compensation, and a 6-million share increase to its equity incentive plan.

Dave Inc. has filed its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 2, 2026.

KinderCare Learning Companies, Inc. has issued its 2026 proxy statement detailing director elections, auditor ratification, and executive compensation advisory votes.

Galera Therapeutics, Inc. has entered into a definitive merger agreement with Obsidian Therapeutics, Inc. in an all-stock transaction expected to close by the third quarter of 2026.

OrthoPediatrics Corp. has scheduled its 2026 annual meeting of stockholders for June 4, 2026, to address director elections, executive compensation, and an incentive plan amendment.

Ceva, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory votes.